P14.29.B QUANTITATIVE BRAIN MRI ANALYSIS IN NEURODEGENERATIVE LANGERHANS CELL HISTIOCYTOSIS

Abstract BACKGROUND Neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) is a severe central nervous system involvement complicating LCH. ND-LCH is characterized by a cerebellar ataxia, pyramidal signs, pseudobulbar palsy, cognitive impairment, and behavioral disturbances. Cerebellar atrophy, the most common MRI finding, has been widely described in the literature. However, the natural history of volumetric changes in the cerebellum has never been examined. In this study, we aim to perform a quantitative analysis of the cerebellar atrophy in ND-LCH patients compared to a control cohort. MATERIAL AND METHODS MRI of patients with ND-LCH were compared to those of controls. An automated cerebellum analysis was performed using the Volbrain software (CERES) and a linear regression analysis was used to score the severity of cerebellar atrophy over time. RESULTS We retrospectively analyzed follow-up MRI of 16 adult patients with ND-LCH compared to those of 22 control patients. We examined an average of four MRIs per patient over a median follow-up period of six years. All patients with ND-LCH exhibit global and cortical cerebellar atrophy over time. The average atrophy rate is -1.86 cm³/year (range -5.90 to 0.34) and is heterogeneous between patients. All cerebellar lobules are affected by atrophy. CONCLUSION Longitudinal quantitative MRI analysis of the cerebellum in ND-LCH: (i) is feasible, (ii) confirms significant global and cortical cerebellar atrophy in patients with ND-LCH over time, (iii) estimates the rate of cerebellar atrophy, and (iv) could be useful as a therapeutic endpoint in a clinically slow-progressing disease. Further studies are needed to validate our findings.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-10-01
DOI
https://doi.org/10.1093/neuonc/noaf193.490
Primary Topic
Histiocytic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P14.29.B QUANTITATIVE BRAIN MRI ANALYSIS IN NEURODEGENERATIVE LANGERHANS CELL HISTIOCYTOSIS

Khê Hoang‐Xuan, Ilyes Aliouat, Jean Donadieu, Eva Pappa et al.
Neuro-Oncology
Histiocytic Disorders and Treatments
article

P14.29.B QUANTITATIVE BRAIN MRI ANALYSIS IN NEURODEGENERATIVE LANGERHANS CELL HISTIOCYTOSIS

Khê Hoang‐Xuan, Ilyes Aliouat, Jean Donadieu, Eva Pappa, Marie‐Odile Habert, K. Mokhtari, Agustí Alentorn, Sébastien Heritier, Lucia Nichelli, Chooyoung Baek, Antoine Del Cul, É. Bayen, Ahmed Idbaïh, Lucas Rincón de la Rosa, Julien Haroche, Alou Sangaré, Loup Guichard, L Leguennec
article en

Abstract

Abstract BACKGROUND Neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) is a severe central nervous system involvement complicating LCH. ND-LCH is characterized by a cerebellar ataxia, pyramidal signs, pseudobulbar palsy, cognitive impairment, and behavioral disturbances. Cerebellar atrophy, the most common MRI finding, has been widely described in the literature. However, the natural history of volumetric changes in the cerebellum has never been examined. In this study, we aim to perform a quantitative analysis of the cerebellar atrophy in ND-LCH patients compared to a control cohort. MATERIAL AND METHODS MRI of patients with ND-LCH were compared to those of controls. An automated cerebellum analysis was performed using the Volbrain software (CERES) and a linear regression analysis was used to score the severity of cerebellar atrophy over time. RESULTS We retrospectively analyzed follow-up MRI of 16 adult patients with ND-LCH compared to those of 22 control patients. We examined an average of four MRIs per patient over a median follow-up period of six years. All patients with ND-LCH exhibit global and cortical cerebellar atrophy over time. The average atrophy rate is -1.86 cm³/year (range -5.90 to 0.34) and is heterogeneous between patients. All cerebellar lobules are affected by atrophy. CONCLUSION Longitudinal quantitative MRI analysis of the cerebellum in ND-LCH: (i) is feasible, (ii) confirms significant global and cortical cerebellar atrophy in patients with ND-LCH over time, (iii) estimates the rate of cerebellar atrophy, and (iv) could be useful as a therapeutic endpoint in a clinically slow-progressing disease. Further studies are needed to validate our findings.

Neuro-OncologyVol. 27(Supplement_3)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Sorbonne Université (FR), Hôpital Armand-Trousseau (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpitaux Universitaires Paris-Ouest (FR), Pitié-Salpêtrière Hospital (FR), Centre Hospitalier Saint-Denis (FR), Institut du Cerveau (FR), Hôpital Charles-Foix (FR)
Openalex Percentile: Top 66%
Histiocytic Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.